Rx Felycin-CA1 (sirolimus delayed-release tablets) for Cats, 12 ct FO51D 5 116–119 126–129 2 120–123

5 116–119 126–129 2 120–123 130–133 2

Available in multiple dosage sizes

leak-proof technology with oversized quilted pockets

Allows hoof mechanics to be applied without removing the shoe

this easy-to-administer oral paste helps promote efficient digestion and improved nutrient utilization

Rx Felycin-CA1 (sirolimus delayed-release tablets) for Cats, 12 ct FO51D 5 116–119 126–129 2 120–123Rx Felycin CA1 (Sirolimus Delayed Release Tablets), 12 Tablets Felycin CA1 (sirolimus delayed release tablets) is the first FDA conditionally approved, once weekly prescription medication designed to help manage ventricular hypertrophy in cats diagnosed with subclinical hypertrophic cardiomyopathy (HCM). This innovative therapy is formulated to help slow disease progression and support long term heart health in affected cats. HCM is a common and often